Alveolar Fibrin Formation Caused by Enhanced Procoagulant and Depressed Fibrinolytic Capacities in Severe Pneumonia: Comparison with the Acute Respiratory Distress Syndrome
Andreas Günther(Cardio-Pulmonary Institute), Werner Seeger(Justus-Liebig-Universität Gießen), Clemens Ruppert(German Center for Lung Research), HEIDI MUTH(Justus-Liebig-Universität Gießen), D. Walmrath(Justus-Liebig-Universität Gießen), PARVIN MOSAVI(Justus-Liebig-Universität Gießen), Friedrich Grimminger(Justus-Liebig-Universität Gießen), Philipp Markart(Universitätsklinikum Gießen und Marburg), S Heinemann(Justus-Liebig-Universität Gießen), Bettina Temmesfeld‐Wollbrück
American Journal of Respiratory and Critical Care Medicine
February 1, 2000
Cited by 299
Related Papers
Clinical classification of pulmonary hypertension
|Journal of the American College of Cardiology|2004|1.9k
Inhaled Iloprost for Severe Pulmonary Hypertension
|New England Journal of Medicine|2002|1.8k
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
|New England Journal of Medicine|2013|1.4k
Mechanisms of disease: pulmonary arterial hypertension
|Nature Reviews Cardiology|2011|784
Pulmonary hypertension in chronic lung disease and hypoxia
|European Respiratory Journal|2018|777